Method of removing laundry ash

Details for Australian Patent Application No. 2005261556 (hide)

Owner Reckitt Benckiser N.V.

Inventors Corradini, Fabio

Agent FB Rice

Pub. Number AU-A-2005261556

PCT Pub. Number WO2006/005919

Priority 0415291.4 08.07.04 GB

Filing date 8 July 2005

Wipo publication date 19 January 2006

International Classifications

C11D 7/26 (2006.01) Compositions of detergents based essentially on non-surface-active compounds

C11D 3/00 (2006.01) Other compounding ingredients of detergent compositions covered in group

C11D 3/02 (2006.01) Other compounding ingredients of detergent compositions covered in group -

C11D 3/20 (2006.01) Other compounding ingredients of detergent compositions covered in group - containing oxygen

C11D 7/08 (2006.01) Compositions of detergents based essentially on non-surface-active compounds

C11D 11/00 (2006.01) Special methods for preparing compositions containing mixtures of detergents

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/005919 Priority application(s): WO2006/005919

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261561-Porphyrin derivatives and their use in photon activation therapy

2005261555-2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer